Detalhe da pesquisa
1.
Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial.
Clin Infect Dis
; 76(3): e1177-e1185, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36164254
2.
Population pharmacokinetics of a combination of miltefosine and paromomycin in Eastern African children and adults with visceral leishmaniasis.
J Antimicrob Chemother
; 78(11): 2702-2714, 2023 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37726401
3.
Blood Parasite Load as an Early Marker to Predict Treatment Response in Visceral Leishmaniasis in Eastern Africa.
Clin Infect Dis
; 73(5): 775-782, 2021 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33580234
4.
Low antileishmanial drug exposure in HIV-positive visceral leishmaniasis patients on antiretrovirals: an Ethiopian cohort study.
J Antimicrob Chemother
; 76(5): 1258-1268, 2021 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33677546
5.
Characterizing the non-linear pharmacokinetics of miltefosine in paediatric visceral leishmaniasis patients from Eastern Africa.
J Antimicrob Chemother
; 75(11): 3260-3268, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32780098
6.
Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives.
Clin Microbiol Rev
; 31(4)2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30158301
7.
Pharmacokinetics, Safety, and Efficacy of an Allometric Miltefosine Regimen for the Treatment of Visceral Leishmaniasis in Eastern African Children: An Open-label, Phase II Clinical Trial.
Clin Infect Dis
; 68(9): 1530-1538, 2019 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30188978
8.
Development of a Multiplexed Assay for Detection of Leishmania donovani and Leishmania infantum Protein Biomarkers in Urine Samples of Patients with Visceral Leishmaniasis.
J Clin Microbiol
; 57(5)2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30787142
9.
Visceral leishmaniasis relapse hazard is linked to reduced miltefosine exposure in patients from Eastern Africa: a population pharmacokinetic/pharmacodynamic study.
J Antimicrob Chemother
; 72(11): 3131-3140, 2017 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28961737
10.
Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.
Malar J
; 13: 458, 2014 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25425434
11.
Leishmania blood parasite dynamics during and after treatment of visceral leishmaniasis in Eastern Africa: A pharmacokinetic-pharmacodynamic model.
PLoS Negl Trop Dis
; 18(4): e0012078, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38640118
12.
Safety and efficacy of paromomycin/miltefosine/liposomal amphotericin B combinations for the treatment of post-kala-azar dermal leishmaniasis in Sudan: A phase II, open label, randomized, parallel arm study.
PLoS Negl Trop Dis
; 17(11): e0011780, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37988402
13.
A global comparative evaluation of commercial immunochromatographic rapid diagnostic tests for visceral leishmaniasis.
Clin Infect Dis
; 55(10): 1312-9, 2012 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22942208
14.
Geographical Variability in Paromomycin Pharmacokinetics Does Not Explain Efficacy Differences between Eastern African and Indian Visceral Leishmaniasis Patients.
Clin Pharmacokinet
; 60(11): 1463-1473, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34105063
15.
Sensitivity and specificity of the Leishmania OligoC-TesT and NASBA-oligochromatography for diagnosis of visceral leishmaniasis in Kenya.
Trop Med Int Health
; 15(7): 806-10, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20487428
16.
Improvements in physical wellbeing over the first two years on antiretroviral therapy in western Kenya.
AIDS Care
; 22(2): 137-45, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20390492
17.
Do the socioeconomic impacts of antiretroviral therapy vary by gender? A longitudinal study of Kenyan agricultural worker employment outcomes.
BMC Public Health
; 9: 240, 2009 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19604381
18.
Long term outcomes and prognostics of visceral leishmaniasis in HIV infected patients with use of pentamidine as secondary prophylaxis based on CD4 level: a prospective cohort study in Ethiopia.
PLoS Negl Trop Dis
; 13(2): e0007132, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30789910
19.
A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia.
PLoS Negl Trop Dis
; 13(1): e0006988, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30653490
20.
Macrophage Activation Marker Neopterin: A Candidate Biomarker for Treatment Response and Relapse in Visceral Leishmaniasis.
Front Cell Infect Microbiol
; 8: 181, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29911074